|
FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system
|
27 June 2019 |
|
FDA seeks public feedback on new drug approval transparency efforts
|
26 June 2019 |
|
FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
|
10 June 2019 |
|
FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer
|
03 June 2019 |
|
FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
|
16 May 2019 |
|
FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome
|
09 May 2019 |
|
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis
|
06 May 2019 |
|
FDA approves first treatment for pediatric patients with lupus
|
26 April 2019 |
|
FDA permits marketing of first medical device for treatment of ADHD
|
23 April 2019 |
|
FDA approves first generic naloxone nasal spray to treat opioid overdose
|
19 April 2019 |
|
FDA approves first targeted therapy for metastatic bladder cancer
|
15 April 2019 |
|
FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture
|
10 April 2019 |
|
FDA expands approved use of metastatic breast cancer treatment to include male patients
|
04 April 2019 |
|
FDA approves treatment for patients with a type of inflammatory arthritis
|
28 March 2019 |
|
FDA approves a new generic valsartan
|
12 March 2019 |
|
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic
|
06 March 2019 |
|
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain
|
14 February 2019 |
|
FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
|
11 February 2019 |
|
FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
|
06 February 2019 |
|
FDA approves first generic Advair Diskus
|
31 January 2019 |